On May 10, 2024, injectable PrEP (pre-exposure prophylaxis) was approved for use in Canada for the prevention of HIV. Apretude (cabotegravir) represents a significant advancement in HIV prevention, offering a promising alternative to daily oral PrEP medications.

Underlying all the hot, steamy scenes of the new limited series, Fellow Travellers, there are facts and realities with which the queer community can identify. These elements help to weave a beautiful story of love and loss.

Gonorrhea is the second most common bacterial STI in Canada. Within gbMSM communities, gonorrhea rates have been increasing. There is a higher prevalence of rectal and throat gonorrhea in gbMSM.

Discovering that you have been diagnosed with HIV can be very overwhelming, but know that this diagnosis is just a fraction of your life story and by no means dictates who you are. With advances made in the pharmaceutical sciences, individuals living with HIV now have the opportunity to lead long and healthy lives. Consistent adherence to prescribed medication therapy further plays an important role, significantly lowering the risk of transmitting HIV to others. Engage in a conversation with your healthcare provider to gain insights into the most effective medication options tailored for your specific needs. Remember, with the right support and information, you can navigate this journey of living with HIV.